embedded image Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.;The present invention also relates to the methods for the treatment of 5-HT2A serotonin receptor mediated disorders in combination with other pharmaceutical agents administered separately or together."/> 3-phenyl-pyrazole derivatives as modulators of the 5-HT<Sub>2A </Sub>serotonin receptor useful for the treatment of disorders related thereto
首页> 外国专利> 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

机译:3-苯基吡唑衍生物作为5-HT 2A 5-羟色胺受体调节剂,可用于治疗与其相关的疾病

摘要

The present invention relates to certain 3-phenyl-pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor.; embedded image Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.;The present invention also relates to the methods for the treatment of 5-HT2A serotonin receptor mediated disorders in combination with other pharmaceutical agents administered separately or together.
机译:本发明涉及某些式(Ⅰa)的3-苯基-吡唑衍生物及其药物组合物,它们可调节5-HT 2A 5-羟色胺受体的活性。 “嵌入式图像” 化合物及其药物组合物涉及可用于治疗血小板聚集,冠状动脉疾病,心肌梗塞,短暂性缺血发作,心绞痛,中风,心房颤动,降低血块形成,哮喘或其症状,躁动或发作的风险的方法。症状,行为障碍,药物性精神病,兴奋性精神病,吉列·德·图雷特综合症,躁狂症,器质性或NOS精神病,精神病性障碍,精神病,急性精神分裂症,慢性精神分裂症,NOS精神分裂症及相关疾病以及睡眠障碍,睡眠障碍,糖尿病相关疾病,进行性多灶性白质脑病等。;本发明还涉及与单独或一起给予的其他药剂组合治疗5-HT 2A 5-羟色胺受体介导的疾病的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号